Table 3

Association with intervention intensity with weight loss achieved and mortality

CharacteristicWeight loss
(from baseline and final reported)*
Mortality
N studies†Weight of studiesMean difference
Random effect model
(kg) (95% CI)
N studiesWeight of studiesTotal deaths/total patients
(mortality rate)
OR
Fixed effect model (95% CI)
Number of interventions per year
6 39%0.84 (0.28 to 1.40)31%5/510 (1.0%)1.45 (0.22 to 9.40)
7– 12 617%2.04 (0.84 to 3.24)62%10/2022 (0.5%)1.34 (0.35 to 5.16)
13– 24 415%2.46 (0.67 to 5.59)64%23/3490 (0.7%)1.20 (0.49 to 2.96)
25 1760%3.53 (2.92 to 4.13)1793%555/13578 (4.1%)0.84 (0.71 to 1.00)
 BMI‡
25– 29 619%1.37 (−0.09 to 2.82)811%23/3890 (0.6%)1.58 (0.64 to 3.90)
30– 35 1648%3.09 (2.11 to 4.06)1422%136/8374 (1.6%)0.93 (0.65 to 1.33)
> 35 623%4.04 (2.47 to 5.61)667%384/6370 (6%)0.86 (0.69 to 1.05)
Comorbidities
Cardiometabolic risk factor present 1656%2.86 (2.10 to 3.63)1890%529/14311 (3.7%)0.90 (0.75 to 1.08)
Healthy population 829%3.03 (1.53 to 4.52)83%12/3458 (0.3%)1.23 (0.39 to 3.89)
Other (arthritis, asthma and mental illness)49%3.35 (2.18 to 4.52)42%7/1275 (0.6%)0.74 (0.16 to 3.37)
Cancer 26%2.70 (1.57 to 3.83)26%2/438 (0.5%)0.98 (0.06 to 15.74)
Age (years)
40– 49 1247%2.29 (0.97 to 3.61)149%50/9868 (0.5%)1.28 (0.71 to 2.30)
50– 59 1239%3.27 (2.38 to 4.15)1269%396/9691 (3.8%)0.84 (0.69 to 1.04)
> 60 714%4.50 (2.76 to 6.25)722%155/2202 (7.0%)0.78 (0.55 to 1.10)
Look AHEAD14%3.40 (3.30 to 3.50)165%376/5145 (7.3%)0.85 (0.69 to 1.05)
All other studies2996%3.01 (2.23 to 3.79)3235%207/14455 (1.4%)0.88 (0.66 to 1.17)
Total 30 100% 2.95 ( 2.35 to 3.55) 32 100% 593/19463 (3.1%) 0.86 ( 0.73 to 1.02)
  • *P<0.0001 for all.

  • †Da Quing excluded for all weight loss.

  • ‡TAIM55 and HCP22 excluded for BMI.

  • BMI, body mass index.